REGmltED COMPANY NUMBER.. D7866804 (England and Wa1esl ReG15TERED CHARITY NUMBER.. 1145185 REPORT OF THE TRUSTEESAND UNAVDITED FINANCIAL STATEMENTS FDR THE YEAR ENDED 31 DECÉMBEft 2025 FOR BYETO CANCER J WHinksLLP Ch8rtefed Actotsnt3nts 19 Highf1 Rood Ed8bèston Blmiinghèm West Mldlènd5 8153BH
B¥ETO CANCER CONTENTS OFTHE FINANCIAL STATEMEN FOR THE YEAR ENDED JI DECEMBER 202S PoBe Report of thETiu5tee5 Independent Examlner's REPDrt Balance Sheet Noie5 to the Flhanclal Statements 7 10 12 Detailed Statement of Financi*l Activitles 13 to 14
BYE TO CANCER REPORT OF THETRU5TEE5 FOR THE YEAR ENDED 31 DECEMBER 2025 08JECIIVfSAND ACTIVITIE5 En5ufing our work dtliyÈrs our alrn5 The focus of our work ACHIEVEMENTS AND PERFORMANCE How t4mè they hJve in ?ny way we can. pagt I
BYE TO CANCER REPORT OF THETRu¥fEES FOR THE YEAfi ENDE9 31 DECEMBER 2025 FINANCIAL REVIEW Resetves poII£¥ FlnanLlal Review As a resiilt, Ihe charity'5 ner as%ets have decrcasEd (rum £16,868 3% at 31 Oocember 2024 to E8.739 a5 at 31 Der.gmbÈr 2025 Galn6 Cuncern FUTURE PLANS STRucfuRE. GOVERNANCE AND MANAGEMENT Goveining documertt dclined by the CornpaniES Act 2006 Bye to CAncer li d company Iimiled by guarantee In EnAlalld and Wales Iiegi%tEred numbpr 78668041 which was iThcorpoTrted on I REcrultment and appolntmeDt of new trustees [ImpdnV. Or£ènK5a¢ionalstrUCture All mattErs Df policy. man3gement and any ther Items as LircurnStance5 requifL' are detp.fmlned by the iru5tge5. Page 2
oyt TO UNCiR
F¢EPOPT OF ThETrVThES
FOI fTrlEYfAI ENDED JI DECEM8Efl 2025
STRUCTURE, OOVT11141fK% MANAGIMENT
Indortlon •nd tr•In14)In4 ¢Tvit¢•i
plrr ol Ihdr Induc¢lan prnuornmi nrwt¢uiMUi •r•ffjodo al Ih•lr f•sponJlbinEl•I Is InNlcsol Bya iocqncgr.
Thls Induttlan Includès In Introduciion io the tbIÉctl>, #rope •Dd pollclts of tho chirl¢V •rrtl nIOrulon grusif
rvppnslbllllle5, 104•thEf wlth • ropy ofih4 cThinyi 50mINI do£umqDt,
REFfflENC ADMIt41rn1TrIIE OEfAILS
Rei15tvTrd Comp•ny
07666104 IEnFland Ind WalNI
IEEilrtertd Ch•dtynumbv
114SJB5
Th¢ i¢d8Q
Coiel¢y
wolvothompion
W
INDEPENDENT EMAMINER'S REPORTTO THE TRUStEES OF 8VE TO CANCER IndEpeDdent examiner'5 report to the trustees of 8yE ta Cancer I'the Company'l I rppoil to the tharity trustees tsn my examination the accoijnts the Compahv For thp yoar ended 31 Decefftber 2025 Independent exèminer's 5tatEmEtit- mattEtS of concern Identifled ètcounllng records were noi kept ITh respect ol the Cumpany a.s required b¥ Scition 386 01 ihe 2006 Att., thi. ai(nunts dn Dot cTrmply with the aCCDunting requirprnents of Section 396 of ilip 2Q06 Act other thdn any rcquifLJment Klrsty lack50n fccA FCA I W Hink- LLP ChartereJ Accounrants Fdgb3sLun ElirminghJm Wesl Midlands BIJ 36H 29 5cptpmber 2026 Page 4
BYETO CANCER srATFMÉNTOF FINANOAL AcnvmES FOR THE YEAR ENDED 31 DECEMBER ZO25 2025 UThrestrlEted lund 2024 Noie5 INCOME AND ENDOWMENYS FROM 51,723 97,684 9,413 Totsl 57,416 107,097 EXPENDITURE .177 30.972 ChaiitabAttlve Direct C05t5 35,879 47.410 SuppDrt costs 21,489 23.271 65,545 101,653 NEf INC(E/(EXPEN0lTuREl 5.444 RECONOLIATIDN OF FUND5 Total funds brought forward 16,868 11,424 TOTAL FUNDS CARRIED FORWARD 8,739 16,868 The DOte5 form part of these Iinancial 5tatement5 Pa8e 5
IAIANry smirr
3024
TOtl
u•rnrtrlgonslblllll¢i lor
.1svrini thor th chirll•blo compony kDop3 occovniinR recordi (hfjl comply wllh SoctlonJ 386 and 387 vl Ihq cUMp•ill
Att 2DJ6 Jn4J
prylrlni lth•n¢lol iijrvmcnlj wlilch alvt • truo )nd luir ¥lew ol Ihe Jr•te vl ol tho chorlt•bl• <ornwny •1 it lh•
ol g•ch IIDincWI yoar And of Its 5urplui or dollill lor QD¢h tlnand•l yo4r In a¢cordinc¢ with th• rwvlr•m•nu ot
39d ond 395 thnd V4hlth oihtTh¥lJo comply wllh tl requlrnmeni• ol Cornp4nieJ A¢1 2ffl6 rvl•iioi io Iln•nd
¥rJEern¢nib, Ja li ippllcffjblp io tho chirlt•blq (Lpany.
7bb• IIMnd•l •tAl#m¢ntJ hDV• b•én prttpArqd In i¢cordonro wllh tho pro110) ippllc4bl• ro chllriioblo romp4nl•i iublocl io tho
Im•ll comp•nlti i¢rne.
T)0 Ilnancl•l ol•iomrnii worv •PPfO¥•LI by lh• gDorLI ol Trusloei thaT{l¢ lor Ilivg on 29 S•pI•mr 2026 •nd WIF• blinqd
onlts
Mr M ODl#- Truito¢
The no¢ lorrn p•rl ol Ih*i• Iiniftrlil il•1omeni
BYE TO CANCER NOTES TO THE FINANCIALSTATEMENTS FOR THE YEAR ÈNDED JI DECEMBER 2025 ACCOUNTING POLICIES BASIS QF PREPARING THE FINANCIAL STATEMENTS INCOME EXPENDITURE TANGIBLE FIXED ASSETS IO% on CD5t 33% reducing balance STOCKS TAXAnON FUND ACCOUNTING DTHER TRADING ACTIV1TIES 202S 2024 4,693 9,413 Page 7
BYETO CANCER NOTES TO THE FINANCIAL STATEMENTS- contitwed FOR THE YEAR ENDED 31 DECEMBER Z025 NET INCOMEIIEXPENDITUREI 2025 2Q24 3,187 4.851 5.D32 3,165 TRUSTEES, REMUNERAT10N AND BENEFITS 2025 2024 12.570 986 12.570 159 13,556 12.729 TRU5fEES' EXPENSES Thpfp wprp nn Iru%tEES' exoense5 Dald for the yEdf Elidpd 31 Dp.EEmber 202J norlor the year ended 31 December 2024. TANfjIBLE FIXEO ASSETS and Computer equipment COST At I january 202S and 31 Deiemb@r 2025 4,099 80.162 3.375 87.636 DEPRECIAMON At l Janudry 2025 Chargc for year 3.775 108 Z6,744 .017 3.337 13 33,856 8.138 At 31 Dpcembp.r 202. 3.883 34.761 3.350 41J94 NEf 800K VALUÈ At 31 December 2025 116 45.401 25 45,642 At 31 Deccmber 2024 324 53,418 38 54.7EO
BYE TO CANCER NOTESTO THE FINANCIALSTATEMENTS- £Ontied FOR THE YEAR ENDEO 31 DEtEMBEFt 2025 TANfjIBLE FIXED A55ETS-contlnue COST At l January 2025 and 31 December 2025 56,235 DEPRECIATION At I lanuBry 2025 34,594 4.851 At31 Der.Ember 2025 39WS NEf BOOK Vv At 31 Decetribpr 2025 16,790 At 31 Detember 2024 STOC 2025 2024 71 271 OEBTOR5: AM(XJNTS FALLING DUE WITHIN ONE YEAR ZQ25 2024 oiher dbtOrS Prepayrnonts 10,455 11,514 10,455 12.183 CREDITORS: AMOUNT5 FALLING DUE INtTHIN ONE YEAR 2025 2024 5.752 lQ,175 S,?S2 9,ID5 8.950 10,314 4.615 Accrued expense5 3.240 39,378 22.667 Page 9
BYE TO CANCER NOTESTOTHE FINANCIALSTATEMENTS- Cuntlnued FOR THE YEAR ENDED al DECEMBER ZO25 CREDITOAS.. AMOUNT5 FALLING DUE AFfER MORE THAN ONE YEAR 2025 2n24 2641 32,593 io. LEA51NG AGREEMENTS ZQ25 2024 5.752 26,841 5,752 3Z,593 38.345 ii. MOVEMENTIN FUNDS Net movemL'nt At At 1.1.25 16,86B 8.739 TOTAL FUN05 16.868 IB,129J 8,739 Re5DufceS expended MDvÈment Unrestiided funds General fund S7,416 165,5451 TOTAL FU14D5 57,416 165 IB.1 Comparatlve5 far mo¥ement fvnd5 movement At 31.12.24 At 1.1 24 11.424 5.444 16,868 TOTAL FUNDS 11.424 5,444 16.868 PaEe IQ
BYE TO CANCER NOTES TO THE FINANCIAL STATEMENT5- continued FOR THE YEAR ENDED 31 DECEMBER 202% ii. MOVEMÉNTIN FUNDS- continued Inr.otning Rc50urCE5 expendpd Movemeiil General fund ID7.097 1101.6531 5.444 TOTAL FUNDS 107.097 1101,6531 5,drt4 Net movement 1 1.1.24 31.12 25 Unrestritted funds 11,424 8.739 TOTAL FUNDS 11.424 Z.6851 MDveineni Cmpended UnrestTiCted funds 164,513 TOTAL FUNDS 164,513 1167.1981 12. RELATEDPARTY DISCLOSURES 13. ULTIMATE CONTROLLING PARTY Page 11
BYETO CANCER NOIE5TOTHE FINANCIALSTATEMENTS- ionrinued FOR THE YEAR ENDED YI DECEM8ER Z025 14. GOING cof4CERt4 Page 12
BYETO CANCER DETAILED 5fATEMENT OF FINANCIAL AUIVITIES FOR THE YEAR ENDED ai DECEMBER 202S 2025 2024 SNCOME AND ENOOWMENTS Donation5 and legacies 5Z,723 97,6B4 4,693 9.413 107,(B7 Total in<oming resourtes 57A16 EXPENDITURE 5,879 2,298 26,764 4.208 ,177 30.972 CharttablE aCtiwfti£s Chomotherapy SUPPDrt 2,052 10,G94 21.655 5.09B 17,22S 2Z,32a 34.681 SupFDrt COS15 MènaEernent 12,57Q 986 12.570 159 13.556 12,729 Flnance 158 133 other 1,052 1.636 319 2,215 562 B.137 220 1,615 547 2.248 597 8.197 1.581 Postage and sl3ti0n.ry 13,921 15.CQS AdditlDnal 329 4.202 464 3.293 Moinr eNyellses 3,531 Pa8c 13
BYETO CANCER ETAILED STATEMEf4T OF FINANCIAL AcrivtriES FOR THE YEAR ENDED 31 DECEMBER 2D25 2025 202 Addltlonal Governanre costs 47 3.832 514 3,862 Accountanry and bookkeepin{ 3.B79 4.276 Total re50urtES expended 65.545 101.653 N¢t leMpenditUfellincornE 5,444 PagE 14